{"log_id": 9094171717391191172, "direction": 0, "words_result_num": 42, "words_result": [{"probability": {"variance": 0.000869, "average": 0.988579, "min": 0.810472}, "location": {"width": 938, "top": 130, "height": 62, "left": 125}, "words": "体和BV(15mg/m2博莱霉素和1.4mg/m2长春新碱)均为静脉给药,盐酸多柔比星脂质体每三周给药"}, {"probability": {"variance": 0.001729, "average": 0.98633, "min": 0.798868}, "location": {"width": 427, "top": 194, "height": 45, "left": 145}, "words": "次,剂量为20mg/m2,BV组治疗周期为三周"}, {"probability": {"variance": 0.000595, "average": 0.992518, "min": 0.852272}, "location": {"width": 892, "top": 229, "height": 56, "left": 174}, "words": "患者接受盐酸多柔比星脂质体治疗的平均周期数为4.8周,BV为3.7周。疗效主要终点指标设"}, {"probability": {"variance": 9e-06, "average": 0.998603, "min": 0.984219}, "location": {"width": 939, "top": 279, "height": 58, "left": 127}, "words": "为治疗反应:完全缓解,临床完全缓解,部分缓解,稳定以及疾病进展。次要终点包括对患者癌性疼"}, {"probability": {"variance": 0.00201, "average": 0.990786, "min": 0.692397}, "location": {"width": 922, "top": 330, "height": 58, "left": 126}, "words": "痛的测定,与全身性损伤相关的症状和征兆的描述,体力状态(KPS)和两种生活质量(QOL)问卷"}, {"probability": {"variance": 7e-06, "average": 0.998755, "min": 0.983518}, "location": {"width": 872, "top": 382, "height": 54, "left": 129}, "words": "其中一种评价QOL的问卷专门针对与艾滋病相关的卡波氏肉瘤。从治疗终点获得的结果如下"}, {"probability": {"variance": 4.3e-05, "average": 0.996639, "min": 0.981949}, "location": {"width": 132, "top": 442, "height": 30, "left": 512}, "words": "脂质体药物组"}, {"probability": {"variance": 0.000416, "average": 0.992299, "min": 0.931104}, "location": {"width": 218, "top": 431, "height": 34, "left": 795}, "words": "博莱霉素和长春新碱组"}, {"probability": {"variance": 9e-06, "average": 0.997024, "min": 0.99408}, "location": {"width": 27, "top": 490, "height": 19, "left": 563}, "words": "0%"}, {"probability": {"variance": 0, "average": 0.996237, "min": 0.996137}, "location": {"width": 19, "top": 482, "height": 19, "left": 895}, "words": "0%"}, {"probability": {"variance": 0, "average": 0.9992, "min": 0.998592}, "location": {"width": 90, "top": 495, "height": 28, "left": 244}, "words": "完全缓解"}, {"probability": {"variance": 4e-06, "average": 0.997929, "min": 0.996045}, "location": {"width": 21, "top": 525, "height": 19, "left": 894}, "words": "0%"}, {"probability": {"variance": 0, "average": 0.99917, "min": 0.9981}, "location": {"width": 133, "top": 535, "height": 34, "left": 224}, "words": "临床完全缓解"}, {"probability": {"variance": 0.000305, "average": 0.989162, "min": 0.958957}, "location": {"width": 50, "top": 532, "height": 22, "left": 555}, "words": "3.3%"}, {"probability": {"variance": 7.2e-05, "average": 0.991721, "min": 0.979678}, "location": {"width": 50, "top": 566, "height": 21, "left": 888}, "words": "4.2%"}, {"probability": {"variance": 0, "average": 0.999478, "min": 0.998728}, "location": {"width": 87, "top": 582, "height": 26, "left": 247}, "words": "部分缓解"}, {"probability": {"variance": 0.000403, "average": 0.985964, "min": 0.951501}, "location": {"width": 48, "top": 575, "height": 22, "left": 558}, "words": "5.5%"}, {"probability": {"variance": 0.001349, "average": 0.979238, "min": 0.905844}, "location": {"width": 56, "top": 618, "height": 22, "left": 556}, "words": "32.2%"}, {"probability": {"variance": 0.001685, "average": 0.97895, "min": 0.896848}, "location": {"width": 57, "top": 609, "height": 22, "left": 882}, "words": "45.0%"}, {"probability": {"variance": 0, "average": 0.999218, "min": 0.99859}, "location": {"width": 46, "top": 625, "height": 25, "left": 268}, "words": "稳定"}, {"probability": {"variance": 0, "average": 0.999109, "min": 0.99817}, "location": {"width": 91, "top": 667, "height": 27, "left": 247}, "words": "疾病进展"}, {"probability": {"variance": 0.001781, "average": 0.975101, "min": 0.902008}, "location": {"width": 46, "top": 661, "height": 21, "left": 560}, "words": "9.9%"}, {"probability": {"variance": 0.001565, "average": 0.976671, "min": 0.908165}, "location": {"width": 57, "top": 650, "height": 25, "left": 885}, "words": "2.7%"}, {"probability": {"variance": 3e-06, "average": 0.998828, "min": 0.992471}, "location": {"width": 370, "top": 707, "height": 40, "left": 184}, "words": "两种治疗中,均无患者表现出完全缓解"}, {"probability": {"variance": 0.002457, "average": 0.984766, "min": 0.668684}, "location": {"width": 894, "top": 740, "height": 57, "left": 186}, "words": "治疗终点的指标中,临床完全缓解/部分缓解差异显著(P<0.001)(盐酸多柔比星脂质体组和BV"}, {"probability": {"variance": 0.002089, "average": 0.987372, "min": 0.742705}, "location": {"width": 941, "top": 790, "height": 57, "left": 140}, "words": "组的反应率分别为38.8%与14.2%),说明盐酸多柔比星脂质体疗效优于BV组。除瘤体大小以外的其"}, {"probability": {"variance": 1.6e-05, "average": 0.997994, "min": 0.977963}, "location": {"width": 942, "top": 839, "height": 58, "left": 141}, "words": "他病灶特征(如厚度、结节、水肿、颜色和疼痛)的结果表明:与基值相比,盐酸多柔比星脂质体治"}, {"probability": {"variance": 0.002938, "average": 0.986375, "min": 0.629319}, "location": {"width": 942, "top": 889, "height": 57, "left": 141}, "words": "疗组有显著的改善(P<0.006)。对卡波氏肉瘤的皮肤和胃肠病灶,盐酸多柔比星脂质体组和BV组在"}, {"probability": {"variance": 0.003086, "average": 0.984454, "min": 0.652455}, "location": {"width": 962, "top": 935, "height": 61, "left": 143}, "words": "基值的变化和体力状态方面的变化差异不显著。QOL中认知功能和穿衣困难两项与基值相比差异显产"}, {"probability": {"variance": 0.00166, "average": 0.985912, "min": 0.827038}, "location": {"width": 367, "top": 1004, "height": 41, "left": 145}, "words": "著,盐酸多柔比星脂质体组优于BV组"}, {"probability": {"variance": 0.001233, "average": 0.989078, "min": 0.767209}, "location": {"width": 892, "top": 1037, "height": 55, "left": 195}, "words": "上述这些研究结果显示,盐酸多柔比星脂质体对CD4计数低(<200CD4淋巴细胞mm3)及有"}, {"probability": {"variance": 0.000311, "average": 0.995536, "min": 0.882235}, "location": {"width": 982, "top": 1074, "height": 72, "left": 145}, "words": "广泛皮肤粘膜内脏疾病的和与艾滋病相关的卡波氏肉瘤患者的治疗有效。与BV相比,盐酸多柔比星"}, {"probability": {"variance": 3e-06, "average": 0.998549, "min": 0.993132}, "location": {"width": 434, "top": 1149, "height": 44, "left": 148}, "words": "脂质体具有更好的顺应性和更高的治疗反应率"}, {"probability": {"variance": 2.1e-05, "average": 0.998003, "min": 0.978024}, "location": {"width": 896, "top": 1185, "height": 55, "left": 195}, "words": "2、目前国内尚未进行卡泊氏肉瘤人群中本品与上市同类产品对比的临床有效性和多次给药安全"}, {"probability": {"variance": 5e-06, "average": 0.998507, "min": 0.99118}, "location": {"width": 542, "top": 1246, "height": 45, "left": 151}, "words": "性的试验。不推荐治疗期间本品与同类产品进行相互替代"}, {"probability": {"variance": 7e-06, "average": 0.997903, "min": 0.992228}, "location": {"width": 153, "top": 1306, "height": 35, "left": 158}, "words": "【药理毒理】"}, {"probability": {"variance": 0.005429, "average": 0.981047, "min": 0.527362}, "location": {"width": 896, "top": 1333, "height": 58, "left": 198}, "words": "多柔比星抗肿瘤的确切机理尚不清楚。一般认为它具有抑制DNA、RNA和蛋白合成的细胞毒作"}, {"probability": {"variance": 2.5e-05, "average": 0.998054, "min": 0.967922}, "location": {"width": 942, "top": 1385, "height": 55, "left": 153}, "words": "用。这是由于这种蒽环类抗生素能嵌入DNA双螺旋的相邻碱基对之间,从而抑制DNA复制所需的"}, {"probability": {"variance": 0, "average": 0.999543, "min": 0.998961}, "location": {"width": 90, "top": 1460, "height": 28, "left": 154}, "words": "解链过程"}, {"probability": {"variance": 2.4e-05, "average": 0.997489, "min": 0.975355}, "location": {"width": 560, "top": 1492, "height": 46, "left": 205}, "words": "以下引自国外上市的盐酸多柔比星脂质体的临床前文献资料"}, {"probability": {"variance": 4.5e-05, "average": 0.997148, "min": 0.966066}, "location": {"width": 894, "top": 1532, "height": 56, "left": 205}, "words": "用盐酸多柔比星脂质体对动物进行多剂量给药的研究中所显示的毒性与人体长期滴注盐酸多柔"}, {"probability": {"variance": 2.1e-05, "average": 0.998085, "min": 0.973292}, "location": {"width": 940, "top": 1582, "height": 55, "left": 159}, "words": "比星的结果相近。盐酸多柔比星脂质体系将盐酸多柔比星包封于PEG化脂质体中,因而其毒性反应"}], "language": 3}